⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397817 | 0.87 | — | — | |
| SCHEMBL17725159 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL13169264 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL8024923 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL5308716 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL7873800 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL7650398 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL14286742 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL15935504 | 0.86 | TSHR (0.39) | — | |
| SCHEMBL31465140 | 0.86 | TSHR (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190284619-A1 | IN SITU PROBE INVERSION PROCESS FOR CONTSTRUCTING PROBE ARRAYS | CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) | 2019-09-19 | — | — | US | disclosed |
| WO-2018102660-A1 | IN SITU PROBE INVERSION PROCESS FOR CONSTRUCTING PROBE ARRAYS | CENTRILLION TECHNOLOGIES, INC. (US) | 2018-06-07 | — | — | WO | disclosed |
| EP-3049426-B1 | GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS | CENTRE NAT RECH SCIENT (FR) | 2017-11-01 | — | — | EP | disclosed |
| US-20160287620-A1 | GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS | UNIVERSITE DE MONTPELLIER (FR) | 2016-10-06 | — | — | US | disclosed |
| EP-2851371-A1 | Glycoclusters and their pharmaceutical use as antibacterials | Centre National de la Recherche Scientifique (CNRS) (FR) | 2015-03-25 | — | — | EP | disclosed |